176 related articles for article (PubMed ID: 16996732)
21. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
de Haas T; Hasselt N; Troost D; Caron H; Popovic M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D; Baas F; Versteeg R; Kool M
Clin Cancer Res; 2008 Jul; 14(13):4154-60. PubMed ID: 18593994
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and clinical implication of a disintegrin and metalloprotease 8 expression in pediatric medulloblastoma.
Zhang R; Yuan Y; Zuo J; Liu W
J Neurol Sci; 2012 Dec; 323(1-2):46-51. PubMed ID: 22959284
[TBL] [Abstract][Full Text] [Related]
23. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
24. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
25. [Expression of c-jun and c-fos oncogene in medulloblastoma and its clinical significance].
Li YY; Mao BY; Dong XH
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):213-5. PubMed ID: 15062038
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic examination of heat shock proteins (HSP 27, HSP 70, and HSP 90) in medulloblastoma.
Hauser P; Hanzély Z; Jakab Z; Oláh L; Szabó E; Jeney A; Schuler D; Fekete G; Bognár L; Garami M
J Pediatr Hematol Oncol; 2006 Jul; 28(7):461-6. PubMed ID: 16825994
[TBL] [Abstract][Full Text] [Related]
27. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
28. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
Als AB; Dyrskjøt L; von der Maase H; Koed K; Mansilla F; Toldbod HE; Jensen JL; Ulhøi BP; Sengeløv L; Jensen KM; Orntoft TF
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4407-14. PubMed ID: 17671123
[TBL] [Abstract][Full Text] [Related]
29. Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.
Tabori U; Baskin B; Shago M; Alon N; Taylor MD; Ray PN; Bouffet E; Malkin D; Hawkins C
J Clin Oncol; 2010 Mar; 28(8):1345-50. PubMed ID: 20142599
[TBL] [Abstract][Full Text] [Related]
30. High expression of stathmin protein predicts a fulminant course in medulloblastoma.
Kuo MF; Wang HS; Kuo QT; Shun CT; Hsu HC; Yang SH; Yuan RH
J Neurosurg Pediatr; 2009 Jul; 4(1):74-80. PubMed ID: 19569914
[TBL] [Abstract][Full Text] [Related]
31. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
32. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
33. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Anticancer Res; 1996; 16(5A):2687-92. PubMed ID: 8917371
[TBL] [Abstract][Full Text] [Related]
34. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
35. Morphologic peculiarities of anaplastic cerebellar tumors and their prognostic significance.
Kunicki A; Stefanko S; Kukulska Z
Acta Med Pol; 1971; 12(3):319-37. PubMed ID: 5112450
[No Abstract] [Full Text] [Related]
36. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
Padovani L; Sunyach MP; Perol D; Mercier C; Alapetite C; Haie-Meder C; Hoffstetter S; Muracciole X; Kerr C; Wagner JP; Lagrange JL; Maire JP; Cowen D; Frappaz D; Carrie C
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):433-40. PubMed ID: 17498567
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
38. Survivin expression levels as independent predictors of survival for osteosarcoma patients.
Osaka E; Suzuki T; Osaka S; Yoshida Y; Sugita H; Asami S; Tabata K; Sugitani M; Nemoto N; Ryu J
J Orthop Res; 2007 Jan; 25(1):116-21. PubMed ID: 17034065
[TBL] [Abstract][Full Text] [Related]
39. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
[TBL] [Abstract][Full Text] [Related]
40. [The correlation of immunohistochemical expression of human manganase-superoxide dismutase and outcome of the patients with medulloblastomas].
Toyonaga S; Kurisaka M; Mori K; Taniguchi N
No To Shinkei; 1996 Feb; 49(2):157-61. PubMed ID: 9046528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
